Entries released in the last month, starting from most recent release to least recent one.
The latest entries may not be immediately available here
or through the BMRB database search. They can be found in "entry lists" under "FTP access".
| Entry ID | Release Date | Title |
|---|---|---|
| 31301 | 2026-04-29 | Structural Studies of an Anti-necroptosis Viral: Human Functional Hetero-amyloid M45:RIPK3 using SSNMR |
| 53720 | 2026-04-28 | Quantifying Mg2+ dependence on conformational equilibrium in the two-state 7SK RNA stem-loop 3 |
| 53721 | 2026-04-28 | Quantifying Mg2+ dependence on conformational equilibrium in the two-state 7SK RNA stem-loop 3 |
| 53727 | 2026-04-27 | "Self-activation" by a C-terminal domain arginine finger regulates GTP hydrolysis in bacterial zinc metallochaperones |
| 53259 | 2026-04-23 | Inhibitor fluorination pattern tunes chemically induced protein dimerization |
| 53609 | 2026-04-22 | 1H, 13C, 15N, and 19F random coil NMR shifts of trifluoromethyl-bearing amino acids |
| 53611 | 2026-04-22 | 1H, 13C, 15N, and 19F random coil NMR shifts of trifluoromethyl-bearing amino acids |
| 35024 | 2026-04-22 | Structural Landscape of Syanodin I Lasso Peptide |
| 53612 | 2026-04-22 | 1H, 13C, 15N, and 19F random coil NMR shifts of trifluoromethyl-bearing amino acids |
| 53331 | 2026-04-21 | Towards site-specific information on PET degrading enzymes using NMR near operational temperature |
| 31296 | 2026-04-20 | Dipeptidyl peptidase IV processing activates Manduca sexta pro-moricin-6: structural basis of enhanced antimicrobial activity. |
| 31251 | 2026-04-20 | Discovery, Expression, and In Silico Safety Evaluation of Honey Truffle Sweetener, a Sweet Protein Derived from Mattirolomyces terfezioides and Produced by Heterologous Expression in Komagataella phaffii |
| 31295 | 2026-04-20 | Dipeptidyl peptidase IV processing activates Manduca sexta pro-moricin-6: structural basis of enhanced antimicrobial activity. |
| 53705 | 2026-04-17 | Characterization of Tryptolinophyllins from the Treefrog Boana boans Expands the Structural and Functional Diversity of the Trypytophyllin Family of Peptides |
| 34999 | 2026-04-15 | Dynamics of non-immunogenic staphylokinase thrombolytics |
| 34996 | 2026-04-15 | Dynamics of non-immunogenic staphylokinase thrombolytics |
| 35000 | 2026-04-15 | Dynamics of non-immunogenic staphylokinase thrombolytics |
| 53650 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53651 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53652 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53653 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53654 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53655 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53656 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53657 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53658 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53659 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53660 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53661 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53662 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53664 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53665 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53666 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53667 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53668 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53669 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53670 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53671 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53672 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53673 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53674 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 52336 | 2026-04-14 | A dynamic structural unit of phase-separated heterochromatin protein 1a as revealed by integrative structural analyses |
| 53626 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53636 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53637 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53638 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53639 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53640 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53641 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53642 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53643 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53644 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53645 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53646 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53647 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53648 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53649 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53675 | 2026-04-14 | Assessing the contribution of rare DNA states to cancer mutational signatures using sequence-specific conformational fingerprinting |
| 53701 | 2026-04-13 | Newton's cradle-like allosteric mechanism explains regulatory RsmE RNA binding. |
| 53702 | 2026-04-13 | Newton's cradle-like allosteric mechanism explains regulatory RsmE RNA binding. |
| 53703 | 2026-04-13 | Newton's cradle-like allosteric mechanism explains regulatory RsmE RNA binding. |
| 53213 | 2026-04-09 | Beyond formic acid: Peptides in carpenter ant venoms aid in disease protection |
| 53225 | 2026-04-09 | Beyond formic acid: Peptides in carpenter ant venoms aid in disease protection |
| 53513 | 2026-04-01 | Manuscripts that utilise GB1-TACC3 |
| 35032 | 2026-04-01 | Xeno amino acid alphabets form peptides with familiar secondary structure |
| 35028 | 2026-04-01 | Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity |